Table 3.
Rumen volatile fatty acids (VFA) concentrations and pH of Bos indicus steers receiving a high-forage (Cynodon dactylon spp.) diet and supplemented or not (CONT; n = 10) with 13 (13NAR; n = 10) or 20 (20NAR; n = 10) ppm of narasin (Zimprova; Elanco Animal Health, São Paulo, SP, Brazil) throughout the experimental period1
Treatments | P-Value2 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Item | CONT | 13NAR | 20NAR | SEM | T | D | T × D | CONT vs. NAR | 13NAR vs. 20NAR |
VFA, mM/L | |||||||||
Acetate | 74.21b | 72.71a | 72.83a | 0.163 | < 0.0001 | < 0.0001 | 0.12 | < 0.0001 | 0.60 |
Propionate | 13.83a | 15.82c | 15.22b | 0.131 | < 0.0001 | < 0.0001 | 0.24 | < 0.0001 | < 0.01 |
Isobutyrate | 0.81 | 0.79 | 0.83 | 0.018 | 0.27 | < 0.0001 | 0.92 | 0.90 | 0.11 |
Butyrate | 8.89b | 8.54a | 8.86b | 0.073 | < 0.01 | < 0.0001 | 0.19 | 0.04 | < 0.01 |
Isovalerate | 1.20 | 1.20 | 1.28 | 0.039 | 0.32 | < 0.0001 | 0.70 | 0.49 | 0.18 |
Valerate | 0.98 | 0.95 | 1.00 | 0.028 | 0.46 | < 0.0001 | 0.94 | 0.75 | 0.23 |
Total VFA | 90.02a | 97.62b | 102.08b | 2.765 | 0.03 | < 0.0001 | 0.97 | 0.01 | 0.25 |
Ac:Pr | 5.40c | 4.63a | 4.81b | 0.048 | < 0.0001 | < 0.0001 | 0.41 | < 0.0001 | 0.01 |
AcBu:Pr | 6.04c | 5.17a | 5.39b | 0.049 | < 0.0001 | < 0.0001 | 0.48 | < 0.0001 | < 0.01 |
Rumen pH | 6.70 | 6.72 | 6.85 | 0.065 | 0.25 | < 0.0001 | 0.33 | 0.33 | 0.17 |
Ammonia, mg/dL | 8.38b | 5.67a | 5.44a | 0.621 | < 0.01 | < 0.0001 | 0.28 | < 0.01 | 0.80 |
1Treatments were offered on a daily basis throughout the experimental period (day 0 to 140). Rumen samples were collected on day 0 (prior to first treatment administration), 14, 28, 56, 84, 112, and 140 of the study, approximately at 0600 h after treatment administration. Rumen ammonia and pH were evaluated every 28 d. Letters within the same line denote differences at the P ≤ 0.05 level.
2T = treatment effect; D = day effect = T × D = treatment × day interaction; CONT vs. NAR = unsupplemented vs. narasin-supplemented animals; 13NAR vs. 20NAR = dose effect of 13 vs. 20 ppm of narasin.